NCT00920556 2019-02-27A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple MyelomaGlaxoSmithKlinePhase 2 Terminated24 enrolled 24 charts
NCT00920803 2017-06-14A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic MetastasesGlaxoSmithKlinePhase 1 Completed9 enrolled